Reyataz
Product Images NDC 54868-4857

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 54868-4857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reyataz 150-mg Capsules (4857)

This is a description of a prescription drug named Reyataz. The container has 60 capsules, with a National Drug Code (NDC) of 54868-4857-0. The drug is distributed by "Physicians Total Care". The lot and expiration date are included, but difficult to read. The drug is manufactured by Bristol-Myers Squibb. The provided number may be a serial or batch number.*

FDA Label Image

Reyataz 300-mg Capsules (5838)

This is a medication label for Reyataz 300g, distributed by Physicians Total Care. The label indicates that the medication is in capsule form and comes in a 30-cap package represented by NDC 54868-5838-0. It also provides the lot number and expiration date of the medication. However, some of the characters are not readable and may impact the accuracy of the information provided.*

FDA Label Image

Figure 1: Mean (sd) Steady-state Plasma Concentrations Of Atazanavir 400 mg (n=13) And 300 mg With Ritonavir (n=10) For Hiv-infected Adult Patients (Reyataz Figure1)

FDA Label Image

Atazanavir Sulfate Chemical Structure (Reyataz Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.